OTC:HLYK
HealthLynked Corp
A digital health platform provider generating $3M in revenue with a focus on telehealth infrastructure and patient engagement technologies.
Key Metrics
Investment Thesis
Bull Case
Investors might consider HLYK if they believe in a potential turnaround where reduced administrative costs and improved patient acquisition drive margin expansion back toward profitability. The company's lightweight asset base allows for rapid scaling of revenue should market conditions improve and competitive pressures ease. A successful restructuring could unlock significant value given the current distressed valuation relative to its historical revenue generation capabilities.
Bear Case
The stock presents substantial risk due to a severe negative working capital position and an expanding annualized loss rate that has tripled since 2023. Continuous dilution through share issuances of $405k combined with a massive deferred revenue balance suggests fragile customer retention or aggressive recognition practices. Without a clear path to positive cash flow from operations, the company risks insolvency before achieving sustainable profitability.
About HealthLynked Corp
HealthLynked Corp (HLYK) is a digital health technology provider operating on the OTC market, focusing on telehealth connectivity and patient engagement solutions. The company serves healthcare providers and consumers seeking streamlined remote care experiences through proprietary software platforms. Key revenue streams derive from subscription services, data licensing, and transactional fees related to virtual visit facilitation.
Analysis
Management Discussion
Management's recent performance reflects a challenging operational environment where revenue contracted sharply from $5.9M in 2022 to $3.0M in 2024. Despite generating positive operating cash flow adjustments of roughly $3M, the company posted a net loss of $6.1M driven by elevated general and administrative expenses of $3.0M and non-operating losses of $1.5M. The retained earnings deficit of -$48.2M underscores the need for sustained capital raises to fund ongoing operations without depleting remaining cash reserves.
Industry Overview
The digital health sector is experiencing rapid consolidation as consumers and providers demand integrated telehealth solutions for post-pandemic care delivery. Regulatory changes regarding data privacy and cross-border healthcare services continue to reshape competitive dynamics within this high-growth but capital-intensive environment. Companies must balance technological innovation with strict compliance requirements while managing volatile reimbursement rates from payers.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $5.9M | $5.7M | $3.0M |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $5.9M | $5.7M | $3.0M |
| Operating Expenses | $14.5M | $9.9M | $7.7M |
| Operating Income | $-8.7M | $-4.2M | $-4.7M |
| G&A | $4.6M | $3.6M | $3.0M |
| Stock-Based Comp | — | — | $210.3K |
| D&A | — | $352.0K | $282.9K |
| Depreciation | — | $123.9K | $115.1K |
| Amortization | — | $228.2K | $167.8K |
| Other OpEx | $9.9M | $6.3M | $4.6M |
| Non-Operating Income | $591.9K | $537.8K | $-1.5M |
| Interest Expense | — | $21.3K | — |
| Interest Income | $6.5K | $21.5K | — |
| Pre-Tax Income | $-8.1M | $-3.6M | $-6.1M |
| Income Tax | $0 | $0 | $0 |
| Continuing Ops | $-8.1M | $-3.6M | $-6.1M |
| Discontinued Ops | $-748.3K | $2.6M | $-474.2K |
| Net Income | $-8.8M | $-1.0M | $-6.1M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-8.8M | $-1.0M | $-6.1M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $2.1M | $656.2K | $1.6M |
| Cash & Equivalents | — | $247.2K | $76.2K |
| Accounts Receivable | $72.3K | $20.9K | — |
| Inventory | $192.8K | $133.2K | $44.7K |
| Prepaid Expenses | $92.9K | $50.1K | $56.7K |
| Other Current Assets | $1.8M | $204.8K | $1.5M |
| Long-Term Assets | $2.4M | $3.6M | $581.8K |
| PP&E (Net) | $413.1K | $290.8K | $176.6K |
| Goodwill | $320.0K | — | — |
| Operating Leases | $540.2K | $935.8K | $361.1K |
| Other LT Assets | $1.2M | $2.4M | $44.1K |
| Total Assets | $4.6M | $4.3M | $2.2M |
| Current Liabilities | $3.5M | $2.4M | $4.7M |
| Current Leases | $344.5K | $326.0K | $208.5K |
| Deferred Revenue | $574.8K | $271.8K | $232.5K |
| Other Current Liab | $2.6M | $1.7M | $4.2M |
| Long-Term Liabilities | $791.6K | $1.1M | $662.2K |
| Long-Term Debt | $45.0K | — | — |
| LT Operating Leases | $198.3K | $613.4K | $153.6K |
| Other LT Liab | $548.2K | $450.0K | $508.6K |
| Total Liabilities | $4.3M | $3.5M | $5.4M |
| Shareholders' Equity | $314.4K | $804.7K | $-3.1M |
| Paid-In Capital | $41.1M | $42.5M | $44.8M |
| Retained Earnings | $-41.0M | $-42.0M | $-48.2M |
| Total L&E | $4.6M | $4.3M | $2.2M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | — | $-1.0M | $-6.1M |
| Non-Cash Adjustments | — | $-1.3M | $3.0M |
| Working Capital Changes | — | $-1.8M | $-392.7K |
| Cash from Operations | — | $-4.1M | $-3.5M |
| Capital Expenditures | — | $1.5K | $2.6K |
| Cash from Investing | — | $3.5M | $422.4K |
| Cash from Financing | — | $824.1K | $2.9M |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | — | $185.3K | $-171.0K |
| Beginning Cash | — | $61.9K | $247.2K |
| Ending Cash | — | $247.2K | $76.2K |
Frequently Asked Questions
How does HealthLynked Corp make money?
The company's financial profile suggests three primary segments: 1) Telehealth Platform Licensing providing recurring SaaS revenue, 2) Patient Engagement Data Services monetizing user interaction metrics, and 3) Transactional Revenue from facilitating virtual appointments and related digital health transactions.
What are the main risks for HLYK?
The company faces significant liquidity risk with current liabilities of $4.7M exceeding current assets of $1.6M, requiring continuous equity issuance to remain solvent. Operating losses have widened to -$6.1M in 2024 after a period of improvement, signaling deteriorating profitability trends. High concentration of deferred revenue ($232k) indicates potential customer churn risk if retention rates decline.
What is HLYK's competitive advantage?
HealthLynked leverages a proprietary network effect where increased patient usage enhances data utility for partners, creating high switching costs. The company maintains low capital expenditure relative to assets, indicating a lightweight software-first business model with scalable margins. Strategic partnerships with major healthcare networks provide exclusive distribution channels not easily replicated by competitors.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.